维普中文期刊产品整合服务
11篇 您的检索式:作者名="Pantangco"
    题名 作者 年代 出处 被引量
1Octrcotide midodrine therapy significantly improves renal function and 30-day survivalin patients with typehepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 0,,03:1
2Octreotide Midodrine therapy significantly improves renal function and 30 - day survival in patients with type 1 hepatorenal syndrome 显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
3Octreotide/Midodrine, therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Diseases And Sciences2007,52,3:1
4Octreotide/Midodrine, therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Diseases And Sciences2007,52,3:1
5Oetrrotide/ midodrine therapy significantly improves renal function and 30 day survival in patients with type 1 hepatorenal syndrome 显示文摘ESRAILIAN E PANTANGCO ER KYULO NL 2007Dig Dis Sci2007,52,:1
6Oetreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome 显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
7Octreotide/Midodrine therapy significantly improves renal function and 30- day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
8Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyu|o NL et ol 2007Dig Dis Sci2007,52,3:1
9Octreotidel Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Dig Dis Sci2007,52,3:1
10Octreotide/Midodrine therapy si gnificantly improves renal function and 30-day survival in patients with type 1hepatorenal syndrome显示文摘Esrailian E Pantangco ER Kyulo NL 2007Digestive Dis-eases And Sciences2007,52,3:1
11Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome显示文摘Eric Esrailian Eugene R. Pantangco Namgyal L. Kyulo Ke-Qin Hu Bruce A. Runyon 2007Digestive Diseases and Sciences2007,,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费